𝔖 Bobbio Scriptorium
✦   LIBER   ✦

VP-1 quasispecies in human infection with polyomavirus BK

✍ Scribed by Chunqing Luo; Hans H. Hirsch; Jeffrey Kant; Parmjeet Randhawa


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
206 KB
Volume
84
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Polyomavirus BK is a recognized cause of nephropathy and hemorrhagic cystitis in kidney or allogeneic hematopoietic stem cell transplant recipients. This study explored a role of genetic variations in capsid protein VP‐1 gene as a factor in viral pathogenesis. VP‐1 was amplified from 7 healthy subjects with viruria, 7 transplant patients with viruria, and 11 patients with viremia or nephropathy. PCR products were cloned and a total of 558 clonal sequences were subjected to phylogenetic analysis using standard methods. VP‐1 quasispecies were found in 25/25 and coinfection with different genotypes in 12/25 subjects. Genotype II was found as an unexpected minority species in 5/25 individuals. Recombinant strains of uncertain biologic significance, which frequently contained genotype II and IV sequences were identified in 9/25 subjects. Viremia/nephropathy group was characterized by (a) greater sequence complexity in whole VP‐1 versus BC loop and BC loop compared to the HI loop, (b) greater intra‐strain genetic diversity in the BC loop compared to whole VP‐1 protein and HI loop, (c) more non‐synonymous substitutions (dN) in the BC loop compared to whole VP‐1 and HI loop, (e) fewer synonymous substitutions (dS) compared to healthy‐viruria group, and (f) selection pressure (dN/dS >1.0) exerted on VP‐1. In conclusion, this study documents frequent occurrence of quasispecies in a host DNA polymerase dependent virus, which is theoretically expected to show high replication fidelity. Quasispecies occur even in healthy subjects with viruria, but evolutionary selection pressure directed at the viral capsid protein (VP‐1) is seen only in patients with viremia or nephropathy. J. Med. Virol. 84:152–161, 2011. © 2011 Wiley Periodicals, Inc.


📜 SIMILAR VOLUMES


VP1 pseudocapsids, but not a glutathione
✍ Andrea Vlastos; Kalle Andreasson; Karin Tegerstedt; Dana Holländerová; Shirin He 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

## Abstract The ability to vaccinate against polyomavirus infection in a T‐cell deficient as well as a normal immune context was studied using polyomavirus major capsid protein (VP1) pseudocapsids (VP1‐ps) or a glutathione‐S‐transferase‐VP1 (GST‐VP1) fusion protein. VP1‐ps (1 or 10 μg) were adminis

BK virus-associated infection in cerebro
✍ Ana Bárcena-Panero; Marijke Van Ghelue; Mahmud Tareq Hassan Khan; Juan E. Echeva 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB

## Abstract While BK virus (BKV) is frequently associated with pathological conditions in bone marrow and renal transplant recipients, BKV infection in neurological individuals has been rarely reported. As a result of a BKV, JCV, and SV40 large T antigen‐specific multiplex PCR on 2,062 cerebrospina

Human parechovirus 1 infections in young
✍ Sisko Tauriainen; Mika Martiskainen; Sami Oikarinen; Maria Lönnrot; Hanna Viskar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

## Abstract The epidemiology, transmission and clinical symptoms of human parechoviruses [HPeV, classified earlier as enteroviruses; echovirus 22 (HPeV1) and echovirus 23 (HPeV2)] remain poorly characterized. Enteroviruses and one parechovirus species, the Ljungan virus, have been associated with t